T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FITB
151
Fifth Third Bancorp
FITB
$52.2B
| $797M | 0.17% |
45,302,909
+9,276,262
| +26% | +$166M |
|
|
HES
152
DELISTED
Hess
HES
| $770M | 0.16% |
12,812,105
+519,852
| +4% | +$30.1M |
|
|
RDS.B
153
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $764M | 0.16% |
13,647,361
-1,235,796
| -8% | -$63.6M |
|
154
SS&C Technologies
SSNC
$18.8B
| $763M | 0.16% |
27,179,354
-4,117,906
| -13% | -$123M |
|
155
Edison International
EIX
$26.6B
| $762M | 0.16% |
9,816,478
-1,442,860
| -13% | -$104M |
|
156
American Express
AXP
$231B
| $757M | 0.16% |
12,458,573
-102,836
| -0.8% | -$6.51M |
|
157
Cooper Companies
COO
$15B
| $752M | 0.16% |
17,539,264
+1,452,948
| +9% | +$58.1M |
|
158
IDEX
IEX
$17.5B
| $747M | 0.16% |
9,098,936
-608,643
| -6% | -$50.6M |
|
|
TFCF
159
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
| $744M | 0.16% |
27,315,760
+5,616,676
| +26% | +$164M |
|
160
Trip.com Group
TCOM
$29.1B
| $735M | 0.16% |
17,849,676
-874,611
| -5% | -$38.2M |
|
|
SHPG
161
DELISTED
Shire pic
SHPG
| $733M | 0.16% |
3,979,512
+1,582,515
| +66% | +$286M |
|
162
AT&T
T
$167B
| $731M | 0.15% |
22,389,285
+365,835
| +2% | +$10.9M |
|
163
APA Corp
APA
$14.4B
| $725M | 0.15% |
13,015,270
-7,537,571
| -37% | -$410M |
|
164
Altria Group
MO
$108B
| $722M | 0.15% |
10,474,091
+1,129,749
| +12% | +$72.4M |
|
165
Air Products & Chemicals
APD
$68.5B
| $721M | 0.15% |
5,487,684
+19,528
| +0.4% | +$2.6M |
|
166
Progressive
PGR
$124B
| $717M | 0.15% |
21,392,461
+245,760
| +1% | +$8.13M |
|
167
NiSource
NI
$20.1B
| $709M | 0.15% |
26,732,498
-787,015
| -3% | -$18.9M |
|
168
Cboe Global Markets
CBOE
$29.6B
| $702M | 0.15% |
10,543,707
+715,015
| +7% | +$45.8M |
|
169
Acuity Brands
AYI
$10.8B
| $691M | 0.15% |
2,785,394
-19,670
| -0.7% | -$4.91M |
|
170
West Pharmaceutical
WST
$24.8B
| $680M | 0.14% |
8,960,969
-7,301
| -0.1% | -$531K |
|
171
Vodafone
VOD
$36.8B
| $678M | 0.14% |
21,947,997
+6,774,418
| +45% | +$220M |
|
|
SE
172
DELISTED
Spectra Energy Corp Wi
SE
| $670M | 0.14% |
18,279,951
+347,477
| +2% | +$11.1M |
|
173
Allegion
ALLE
$14.3B
| $665M | 0.14% |
9,574,726
-126,550
| -1% | -$8.41M |
|
174
MSCI
MSCI
$40.9B
| $645M | 0.14% |
8,362,585
+35,645
| +0.4% | +$2.7M |
|
175
Bruker
BRKR
$8.66B
| $644M | 0.14% |
28,318,830
+20,885
| +0.1% | +$558K |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.